Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Methotrexate × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76 Leukemia 58 Lymphoma 44 Leukemia, Myeloid, Acute 31 Burkitt Lymphoma 31 Myelodysplastic Syndromes 25 Lymphoma, Non-Hodgkin 23 Lymphoma, Mantle-Cell 23 Hodgkin Disease 23 Lymphoma, Large B-Cell, Diffuse 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Lymphoma, Follicular 18 Recurrence 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Graft vs Host Disease 17 Lymphoma, B-Cell, Marginal Zone 13 Congenital Abnormalities 13 Multiple Myeloma 12 Leukemia, Myelomonocytic, Chronic 12 Lymphoma, Large-Cell, Immunoblastic 11 Leukemia, Myeloid, Chronic-Phase 11 Leukemia, Myeloid, Accelerated Phase 11 Breast Neoplasms 11 Myeloproliferative Disorders 10 Lymphoma, Large-Cell, Anaplastic 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Hematologic Neoplasms 10 Blast Crisis 10 Primary Myelofibrosis 9 Osteosarcoma 9

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡